GU cancer highlights from ASCO 2026
About this episode
The episode discusses key highlights in genitourinary cancer from the 2026 ASCO Annual Meeting.
In this week’s VJOncology podcast, we present highlights in genitourinary cancer from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Join Andrew Armstrong of Duke University Medical Center, Srikala Sridhar of the Princess Margaret Cancer Centre, Tian Zhang of UT Southwestern Medical Center, and Lucia Nappi of the University of British Columbia as they discuss key data and clinical perspectives across prostate, bladder, kidney and testicular cancer, including the PROTEUS, CHAMP, TALAPRO-3, A-DREAM and SWOG S1823 trials, as well as the role of enfortumab vedotin and pembrolizumab in bladder cancer.
More episodes of VJOncology Podcast
- Top updates from the ESMO Gastrointestinal Cancers Congress 2026
- Highlights in lung cancer from ASCO 2026: LIBRETTO-432, CROWN, and more
- Breast cancer highlights from ASCO 2026
Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.